【摘要】：目的探討成軟骨相關(guān)miR-4287對(duì)人軟骨細(xì)胞聚蛋白多糖酶-1(a disintegrin and metalloproteinase with thrombospondin motif 4,ADAMTS4)調(diào)控作用及其機(jī)制。方法取自愿捐贈(zèng)的膝關(guān)節(jié)正常及骨關(guān)節(jié)炎軟骨組織,采用實(shí)時(shí)熒光定量PCR檢測miR-4287和ADAMTS4 mRNA表達(dá)量;然后分離培養(yǎng)軟骨細(xì)胞,取第1代骨關(guān)節(jié)炎細(xì)胞,給予IL-1β處理,觀察其對(duì)軟骨細(xì)胞miR-4287和ADAMTS4 mRNA表達(dá)的影響;分別給予MAPK信號(hào)通路抑制劑SP600125以及NF-κB信號(hào)通路抑制劑SN50預(yù)處理后聯(lián)合IL-1β刺激,觀察IL-1β介導(dǎo)的信號(hào)通路對(duì)軟骨細(xì)胞miR-4287和ADAMTS4 mRNA表達(dá)的影響;分別轉(zhuǎn)染miR-4287模擬物及其陰性對(duì)照、miR-4287抑制物及其陰性對(duì)照,觀察miR-4287調(diào)控軟骨細(xì)胞ADAMTS4 mRNA及蛋白的表達(dá)。熒光素酶報(bào)告實(shí)驗(yàn)驗(yàn)證miR-4287與ADAMTS4 mRNA 3’非翻譯區(qū)(untranslated region,UTR)的直接結(jié)合效應(yīng)。結(jié)果與正常軟骨組織比較,骨關(guān)節(jié)炎軟骨組織miR-4287相對(duì)表達(dá)量下降,ADAMTS4 mRNA相對(duì)表達(dá)量上升,比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)。IL-1β下調(diào)軟骨細(xì)胞miR-4287表達(dá)、上調(diào)ADAMTS4 mRNA表達(dá),與未經(jīng)IL-1β處理的軟骨細(xì)胞相比差異均有統(tǒng)計(jì)學(xué)意義(P0.05)。經(jīng)IL-1β介導(dǎo)的信號(hào)通路抑制劑預(yù)處理后,軟骨細(xì)胞miR-4287相對(duì)表達(dá)量上升,ADAMTS4 mRNA相對(duì)表達(dá)量降低,與未經(jīng)信號(hào)通路抑制劑預(yù)處理細(xì)胞相比,差異均有統(tǒng)計(jì)學(xué)意義(P0.05)。轉(zhuǎn)染miR-4287模擬物后,軟骨細(xì)胞內(nèi)ADAMTS4 mRNA及蛋白表達(dá)均降低(P0.05);而轉(zhuǎn)染miR-4287抑制物后,軟骨細(xì)胞內(nèi)ADAMTS4 mRNA及蛋白表達(dá)均升高(P0.05)。無論結(jié)合位點(diǎn)為野生型或突變型,過表達(dá)miR-4287均不能改變報(bào)告載體的熒光素酶活性(P0.05)。結(jié)論成軟骨相關(guān)miR-4287可能是一種與軟骨退變相關(guān)的miRNA。miR-4287能調(diào)控人軟骨細(xì)胞ADAMTS4表達(dá),但不是通過靶向結(jié)合mRNA 3’UTR的方式發(fā)揮作用,其具體機(jī)制有待進(jìn)一步研究。
[Abstract]:Objective to investigate the regulatory effect of chondrogenic miR-4287 on human chondrocyte polyproteoglycan enzyme 1 (a disintegrin and metalloproteinase with thrombospondin motif 4 (ADAMTS4) and its mechanism. Methods the normal and osteoarthritis cartilage tissues of knee joint were collected and the expression of miR-4287 and ADAMTS4 mRNA were detected by real-time fluorescence quantitative PCR, then the chondrocytes were isolated and cultured, and the first generation of osteoarthritis cells were collected and treated with IL-1 尾. The effects of SN50 on the expression of miR-4287 and ADAMTS4 mRNA in chondrocytes were observed, and the effects of IL-1 尾 -mediated signal pathway on miR-4287 and ADAMTS4 mRNA expression in chondrocytes were observed after pretreatment with MAPK signal pathway inhibitor SP600125 and NF- 魏 B signal pathway inhibitor SN50 with IL-1 尾 stimulation. The expression of ADAMTS4 mRNA and protein in chondrocytes was observed by transfection of miR-4287 analogue and its negative control inhibitor miR-4287 and negative control respectively. Luciferase reporting experiments demonstrated the direct binding effect of miR-4287 to ADAMTS4 mRNA 3 'untranslated region (untranslated region,UTR). Results compared with normal chondrocytes, the relative expression of miR-4287 in osteoarthritis cartilage decreased and the relative expression of ADAMTS4 mRNA increased. The difference was statistically significant (P0.05) .IL-1 尾 down-regulated miR-4287 expression in chondrocytes and up-regulated ADAMTS4 mRNA expression. Compared with the chondrocytes without IL-1 尾 treatment, the difference was statistically significant (P0.05). After pretreatment with signal pathway inhibitor mediated by IL-1 尾, the relative expression of miR-4287 in chondrocytes increased and the relative expression of ADAMTS4 mRNA in chondrocytes decreased, compared with the cells without signal pathway inhibitor pretreatment, the difference was statistically significant (P0.05). The expression of ADAMTS4 mRNA and protein in chondrocytes decreased after transfection of miR-4287 mimics (P0.05), while the expression of ADAMTS4 mRNA and protein in chondrocytes increased after transfection of miR-4287 inhibitors (P0.05). Overexpression of miR-4287 could not change the luciferase activity of the reporter vector, regardless of whether the binding site was wild type or mutant type (P0.05). Conclusion chondrogenic miR-4287 may be a kind of miRNA.miR-4287 associated with cartilage degeneration that can regulate the expression of ADAMTS4 in human chondrocytes, but not by targeting mRNA 3'UTR, and its specific mechanism needs further study.
【作者單位】： 中山大學(xué)附屬第一醫(yī)院關(guān)節(jié)外科;貴州醫(yī)科大學(xué)附屬醫(yī)院骨科;
【基金】：國家自然科學(xué)基金資助項(xiàng)目(81572171) 廣東省自然科學(xué)基金資助項(xiàng)目(2014A03031385)~~
【分類號(hào)】：R684.3

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 楊運(yùn)東 ,陳基長;不同施加因素對(duì)軟骨細(xì)胞的影響[J];中醫(yī)正骨;2002年09期

2 黃建榮;劉尚禮;李衛(wèi)平;李建華;沈慧勇;宋衛(wèi)東;韓運(yùn);;關(guān)節(jié)軟骨缺損修復(fù)的基因治療實(shí)驗(yàn)——人胰島素樣生長因子I基因轉(zhuǎn)染軟骨細(xì)胞及其在軟骨細(xì)胞中的表達(dá)[J];中國臨床康復(fù);2005年38期

3 黃正;傅文_g;馮偉;張鳳華;朱雅萍;魏立;周琦;袁石福;杜寧;黃好;;不同類型靜水壓對(duì)兔軟骨細(xì)胞表型的影響[J];中國中醫(yī)骨傷科雜志;2007年02期

4 李昊;;不同年齡兔軟骨細(xì)胞培養(yǎng)和形態(tài)學(xué)研究[J];山西職工醫(yī)學(xué)院學(xué)報(bào);2008年01期

5 宋之明;張紹昆;孫洋;任琦;;逆轉(zhuǎn)錄病毒載體介導(dǎo)人胰島素樣生長因子-I在軟骨細(xì)胞中的表達(dá)[J];中國老年學(xué)雜志;2011年10期

6 王德春;宋后燕;陳崢嶸;;軟骨細(xì)胞培養(yǎng)及其臨床應(yīng)用[J];中華創(chuàng)傷雜志;1996年05期

7 ;軟骨細(xì)胞再生軟骨新技術(shù)[J];中國科技信息;1999年Z4期

8 王鑫;靳雷;肖春;顏世舉;孫聰;張開亮;裘秀春;范清宇;馬保安;;人軟骨細(xì)胞壓力實(shí)驗(yàn)?zāi)Ｐ偷慕⑴c評(píng)估[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2014年10期

9 張建黨,盧世璧,袁玫,黃靖香,趙斌,孫明學(xué),崔雪梅,許文靜;關(guān)節(jié)軟骨源性微載體與軟骨細(xì)胞的體外相容性[J];中華創(chuàng)傷骨科雜志;2005年09期

10 肖春;靳雷;王鑫;顏世舉;韓康;張開亮;孫聰;裘秀春;范清宇;馬保安;;周期性靜水壓對(duì)人軟骨細(xì)胞活性的時(shí)間依賴性影響[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2014年01期

相關(guān)會(huì)議論文 前10條

1 孫明學(xué);郭全義;張莉;眭翔;趙斌;袁玫;盧世璧;;復(fù)合自體軟骨細(xì)胞的藻酸鈣修復(fù)養(yǎng)膝關(guān)節(jié)負(fù)重區(qū)軟骨缺損的實(shí)驗(yàn)研究[A];全國骨科臨床研究新進(jìn)展研討會(huì)暨學(xué)習(xí)班論文集[C];2006年

2 李具寶;徐翔峰;李兆福;狄朋桃;劉維超;彭江云;亓峰;張磊;熊啟良;俞U，

本文編號(hào)：2236664